Vice President Research
Bellicum is a clinical stage company focused on developing novel cellular immunotherapies for certain cancers and orphan inherited blood disorders.
Experienced Director in the biotechnology industry and in academia. Current focus is the development of immunotherapies to cancer, specifically CAR-T and CAR-NK based immunotherapies regulated by small molecules. Has led Discovery programs and is experienced in translational studies for clinical development. Extensive background in Molecular Biology, Immunology, Cell Biology, Developmental Biology and Chemical Biology.
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you're looking to find the email of Henri Bayle at Bellicum Pharmaceuticals then you've come to the right place.
Wondering if it's henri@bellicum.com, henri.bayle@bellicum.com, bayle@bellicum.com, or hbayle@bellicum.com? We have the answers for you.